Driving a global effort against Alzheimer’s
The Davos Alzheimer’s Collaborative is a global initiative to progress the discovery, testing and delivery of precision interventions for Alzheimer’s disease.
Eisai is a leading global research and development-based pharmaceutical company headquartered in Japan. Its human healthcare philosophy is “giving first thought to patients and their families and to increasing the benefits healthcare provides”. With approximately 10,000 employees working in its global network of R&D facilities, manufacturing sites and marketing subsidiaries, it strives to realize this philosophy by delivering innovative products to address unmet medical needs, with a particular focus on neurology and oncology. Its mission extends to patients worldwide through investments and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.